Gelteq Limited (GELS)

NASDAQ: GELS · Real-Time Price · USD

0.7600

+0.0200 (2.70%)

At close: Mar 20, 2026, 4:00 PM EDT

0.7499

-0.0101 (-1.33%)

After-hours: Mar 20, 2026, 4:00 PM EDT

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Development and Testing of a GEL Based Delivery System for Humans and Animals	413.13K	143.31K	342.90K	372.07K	159.87K
Development and Testing of a GEL Based Delivery System for Humans and Animals Growth	188.27%	-58.21%	-7.84%	132.73%	-
Total	413.13K	143.31K	342.90K	372.07K	159.87K
Total Growth	188.27%	-58.21%	-7.84%	132.73%	-

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
United States of America	125.65K	-	79.84K	19.96K	-
United States of America Growth	-	-	299.99%	-	-
Australia	40.00K	-	-	-	159.87K
China	-	-	-	127.58K	-
Total	165.65K	-	79.84K	147.54K	159.87K
Total Growth	-	-	-45.88%	-7.71%	-

Source: S&P Global Market Intelligence.